锡克
髓系白血病
癌症研究
转录因子
白血病
下调和上调
Hox基因
背景(考古学)
生物
髓样
细胞生物学
信号转导
酪氨酸激酶
免疫学
基因
遗传学
古生物学
作者
Sebastian Mohr,Carmen Doebele,Federico Comoglio,Tobias Berg,Julia Beck,Hanibal Bohnenberger,Gabriela Alexe,Jasmin Corso,Philipp Ströbel,Astrid Wachter,Tim Beißbarth,Frank Schnütgen,Anjali Cremer,Nadine Haetscher,Stefanie Göllner,A. MAUREEN ROUHI,Lars Palmqvist,Michael A. Rieger,Timm Schroeder,Halvard Bönig
出处
期刊:Cancer Cell
[Cell Press]
日期:2017-04-01
卷期号:31 (4): 549-562.e11
被引量:105
标识
DOI:10.1016/j.ccell.2017.03.001
摘要
The transcription factor Meis1 drives myeloid leukemogenesis in the context of Hox gene overexpression but is currently considered undruggable. We therefore investigated whether myeloid progenitor cells transformed by Hoxa9 and Meis1 become addicted to targetable signaling pathways. A comprehensive (phospho)proteomic analysis revealed that Meis1 increased Syk protein expression and activity. Syk upregulation occurs through a Meis1-dependent feedback loop. By dissecting this loop, we show that Syk is a direct target of miR-146a, whose expression is indirectly regulated by Meis1 through the transcription factor PU.1. In the context of Hoxa9 overexpression, Syk signaling induces Meis1, recapitulating several leukemogenic features of Hoxa9/Meis1-driven leukemia. Finally, Syk inhibition disrupts the identified regulatory loop, prolonging survival of mice with Hoxa9/Meis1-driven leukemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI